USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Elekta Limited

USPTO PatentsView assignee record - 190 granted patents across 36 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company

The verdict

According to USPTO PatentsView, Elekta ranks #2,079 of 49,997 tracked US assignees by granted-patent volume, with 190 patents across 36 technology areas.

#2,079
of 49,997 US assignees by volume
Top 6%
by Innovation Score (57.0/100)
20.8
avg claims per patent
+155%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2079 · Foreign Corporation #2,079 · 190 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MID 190 grants
  • TOP-DECILE #2,079/49,997
  • PHOTO-FINISH AutoStore Technology…
  • CPC-FOCUS A61N · 36 areas
  • INNOV-PAR 57.0/100
  • CLAIMS-DENSE 20.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +155% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: AutoStore Technology AS (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Elekta

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Elekta's Innovation Score is 57.0/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Elekta's grants concentrate

Elekta Limited is a focused PatentsView assignee: 36 CPC subclasses with 82.1% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2020 (32 grants) versus a trough of 2 in 2015. By volume, Elekta sits between Stolle Machinery Company, LLC and Rigel Pharmaceuticals, Inc..

Elekta's three-year grant acceleration

From 2019–2021 to 2022–2024, Elekta Limited moved from 78 to 60 grants (0.77x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,936. See the growth leaderboard.

Who files at Elekta's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Elekta holds 190 patents at rank #2,079, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Elekta

By rank, the assignees closest to #2,079 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Elekta's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Elekta, neither rank-band nor same-CPC leaders (those blocks stay above).

Elekta's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 6% higher than 94% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

010203040 20152016201720182019202020212022202320242025 34
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Elekta Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 1.1%
2016 2 1.1%
2017 3 1.6%
2018 11 5.8%
2019 26 13.7%
2020 32 16.8%
2021 20 10.5%
2022 19 10.0%
2023 17 8.9%
2024 24 12.6%
2025partial year 34 17.9%

Which technologies does Elekta Limited patent most?

Top 15 of 36 technology areas

Where it ranks

Overall rank by patents

#2,079

of 49,997 tracked assignees

Innovation Score

57.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Elekta Limited's patent record in context - here's where to go next.

  • Elekta Limited's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 82.1% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #2,079 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Elekta Limited against Stolle Machinery Company, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 57.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.